The modified live canine parvovirus (CPV) vaccine was used to vaccinate intranasally twenty‐five pups with maternal antibody. The vaccine was able to overcome the interference of maternal immunity in rates of 100 %, 72.7 % and 17.6 % in pups with haemagglutination inhibition antibody titre of 40, 80 and 160 respectively. © 1994 Blackwell Verlag GmbH

Intranasal vaccination of pups with maternally derived antibodies with a modified live canine parvovirus

BUONAVOGLIA, Canio;CAVALLI, Alessandra;VOIGT, Valentina;BUONAVOGLIA, Domenico;DE CAPRARIIS, Donato;
1994-01-01

Abstract

The modified live canine parvovirus (CPV) vaccine was used to vaccinate intranasally twenty‐five pups with maternal antibody. The vaccine was able to overcome the interference of maternal immunity in rates of 100 %, 72.7 % and 17.6 % in pups with haemagglutination inhibition antibody titre of 40, 80 and 160 respectively. © 1994 Blackwell Verlag GmbH
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11586/183123
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 9
  • ???jsp.display-item.citation.isi??? ND
social impact